HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.
HIV-1 transactivator Tat has greatly contributed to our understanding of transcription elongation by RNAPII. We purified HIV-1 Tat-associated factors from HeLa nuclear extract and show that Tat forms two distinct and stable complexes. Tatcom1 consists of the core active P-TEFb, MLL-fusion partners involved in leukemia (AF9, AFF4, AFF1, ENL, and ELL), and PAF1 complex. Importantly, Tatcom1 formation relies on P-TEFb while optimal CDK9 CTD-kinase activity is AF9 dependent. MLL-fusion partners and PAF1 are required for Tat transactivation. Tatcom2 is composed of CDK9, CycT1, and 7SK snRNP lacking HEXIM. Tat remodels 7SK snRNP by interacting directly with 7SK RNA, leading to the formation of a stress-resistant 7SK snRNP particle. Besides the identification of factors required for Tat transactivation and important for P-TEFb function, our data show a coordinated control of RNAPII elongation by different classes of transcription elongation factors associated in a single complex and acting at the same promoter.
Sobhian
Bijan
B
Laboratoire de Virologie Moléculaire, Institut de Génétique Humaine, CNRS-UPR1142, Montpellier, France. bijan.sobhian@igh.cnrs.fr
Laguette
Nadine
N
Yatim
Ahmad
A
Nakamura
Mirai
M
Levy
Yves
Y
Kiernan
Rosemary
R
Benkirane
Monsef
M
D001665:Binding Sites; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism*; D042863:Cyclin-Dependent Kinase 9 / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D015497:HIV-1 / Q000235:genetics* / Q000378:metabolism; D006367:HeLa Cells; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D046912:Multiprotein Complexes; D051788:Myeloid-Lymphoid Leukemia Protein / Q000378:metabolism; D009687:Nuclear Proteins / Q000378:metabolism; D015514:Oncogene Proteins, Fusion / Q000378:metabolism; D042925:Positive Transcriptional Elongation Factor B / Q000378:metabolism; D011401:Promoter Regions, Genetic; D012367:RNA, Viral / Q000096:biosynthesis*; D012097:Repressor Proteins / Q000378:metabolism; D017411:Ribonucleoproteins, Small Nuclear / Q000235:genetics / Q000378:metabolism*; D013312:Stress, Physiological; D014157:Transcription Factors; D015533:Transcriptional Activation; D035602:Transcriptional Elongation Factors / Q000378:metabolism; D014162:Transfection; D054322:tat Gene Products, Human Immunodeficiency Virus / Q000235:genetics / Q000378:metabolism*
C471348:AFF4 protein, human; D004268:DNA-Binding Proteins; C090862:ELL protein, human; C497422:KMT2A protein, human; C489901:MLLT3 protein, human; D046912:Multiprotein Complexes; D009687:Nuclear Proteins; D015514:Oncogene Proteins, Fusion; C501972:PAF1 protein, human; D012367:RNA, Viral; D012097:Repressor Proteins; D017411:Ribonucleoproteins, Small Nuclear; D014157:Transcription Factors; D035602:Transcriptional Elongation Factors; D054322:tat Gene Products, Human Immunodeficiency Virus; D051788:Myeloid-Lymphoid Leukemia Protein; C081449:AFF1 protein, human; D011495:Histone-Lysine N-Methyltransferase; D042925:Positive Transcriptional Elongation Factor B; C467969:CDK9 protein, human; D042863:Cyclin-Dependent Kinase 9
Cell. 2005 Apr 22;121(2):167-78
15851025
Nucleic Acids Res. 2008 Apr;36(7):2219-29
18281698
Mol Cell Biol. 2004 Jun;24(12):5094-105
15169877
Mol Cell. 2006 Aug 4;23(3):297-305
16885020
Cell. 2009 May 1;137(3):459-71
19410543
Leukemia. 2009 Aug;23(8):1490-9
19262598
Annu Rev Biochem. 1999;68:301-19
10872452
EMBO J. 2006 Apr 19;25(8):1690-9
16601680
Mol Cell. 2003 Mar;11(3):721-9
12667454
Blood. 2007 Dec 15;110(13):4445-54
17855633
Mol Cell. 2005 Aug 19;19(4):535-45
16109377
Mol Cell. 2010 Feb 12;37(3):429-37
20159561
J Biomed Sci. 2002 May-Jun;9(3):234-45
12065898
Mol Cell. 2001 Aug;8(2):327-37
11545735
J Biol Chem. 2008 Apr 4;283(14):9040-8
18223296
Curr Opin Cell Biol. 2008 Jun;20(3):334-40
18513937
Cell. 1998 Feb 20;92(4):451-62
9491887
Cancer Cell. 2010 Feb 17;17(2):198-212
20153263
Mol Cell. 2009 Oct 9;36(1):75-87
19818711
Hum Mol Genet. 2007 Jan 1;16(1):92-106
17135274
J Virol. 2009 Jan;83(2):1036-44
18971272
PLoS Pathog. 2007 Oct 12;3(10):1459-69
17937499
FASEB J. 1998 Nov;12(14):1437-46
9806752
Science. 2008 Mar 28;319(5871):1791-2
18369138
Science. 2008 Dec 19;322(5909):1804-5
19095933
Haematologica. 2009 Jul;94(7):984-93
19535349
Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8575-9
18562276
Genes Dev. 2008 May 15;22(10):1356-68
18483222
Mol Cell. 2005 Aug 19;19(4):523-34
16109376
Retrovirology. 2007 May 30;4:36
17537237
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19286-91
19880750
Cell. 2007 Jul 13;130(1):77-88
17632057
EMBO Rep. 2009 Aug;10(8):894-900
19575011
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7798-803
19416841
J Cell Physiol. 2005 Dec;205(3):463-70
16152622
Nucleic Acids Res. 2007;35(13):4347-58
17576689
Genes Dev. 2004 Oct 15;18(20):2437-68
15489290
Nature. 2001 Nov 15;414(6861):322-5
11713533
Mol Cell. 2007 Jul 20;27(2):262-74
17643375
Methods Enzymol. 2003;370:430-44
14712665
J Biol Chem. 2002 Jun 21;277(25):22215-21
11956210
Mol Genet Genomics. 2007 Feb;277(2):101-14
17001490
EMBO Rep. 2008 Jun;9(6):569-75
18483487
Nature. 2001 Nov 15;414(6861):317-22
11713532
Biochem Cell Biol. 2009 Feb;87(1):65-75
19234524
EMBO J. 2007 Jan 24;26(2):424-35
17245432
J Virol. 2004 Dec;78(24):13522-33
15564463
Trends Genet. 2008 Jun;24(6):280-8
18457900
Mol Cell Biol. 2008 Feb;28(3):967-76
18039861